Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (23.02.2026)
HOCH Abgang Schlüsselpersonen (23.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 23.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | corporated by reference in this Item 1.01. Item 5.02 Departure of Directors or Certain Officers; Election of Directors |
| 23.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 03.07.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 01.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
Stammdaten
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Unternehmen & Branche
| Name | Sharps Technology Inc. |
|---|---|
| Ticker | STSS |
| CIK | 0001737995 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Instruments & Supplies |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 44,3 Mio. USD |
| Beta | 2,07 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 204,120 | -282,502,126 | -11.16 | 269,075,173 | 264,380,146 |
| 2025-09-30 | 10-Q | 83,622 | -105,333,293 | -4.33 | 443,960,043 | 433,214,157 |
| 2025-06-30 | 10-Q | 222,722 | 3,559,307 | 3.58 | 17,085,197 | 14,539,670 |
| 2025-03-31 | 10-Q | 1,928,834 | 38.62 | 18,916,096 | 10,135,328 | |
| 2024-12-31 | 10-K | -9,296,201 | -###.## | 7,313,748 | 1,996,129 | |
| 2024-09-30 | 10-Q | -1,685,060 | -379.55 | 11,253,898 | 6,505,703 | |
| 2024-06-30 | 10-Q | -2,102,327 | -643.64 | 9,932,221 | 7,217,198 | |
| 2024-03-31 | 10-Q | -982,386 | -347.50 | 9,803,822 | 6,860,630 | |
| 2023-12-31 | 10-K | -9,841,638 | -16.61 | 11,789,268 | 7,934,285 | |
| 2023-09-30 | 10-Q | -2,022,344 | -3.77 | 14,371,620 | 10,595,569 | |
| 2023-06-30 | 10-Q | -2,605,825 | 0.22 | 11,794,135 | 8,689,269 | |
| 2023-03-31 | 10-Q | -2,111,830 | -0.20 | 13,531,086 | 10,966,772 | |
| 2022-12-31 | 10-K | -4,639,662 | -0.57 | 11,839,656 | 9,641,134 | |
| 2022-09-30 | 10-Q | -2,398,123 | -0.26 | 13,533,212 | 9,914,182 | |
| 2022-06-30 | 10-Q | 477,754 | 0.06 | 15,026,122 | 12,002,004 | |
| 2022-03-31 | 10-Q | -1,869,721 | 4,935,262 | 1,627,436 | ||
| 2021-12-31 | 10-K | -4,664,412 | 5,902,350 | 3,136,197 | ||
| 2021-09-30 | 10-Q | -1,341,248 | 3,384,672 | |||
| 2021-06-30 | 10-Q | -810,647 | 2,859,490 | |||
| 2021-03-31 | 10-Q | -914,689 | 1,505,371 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-01-16 | Saba Capital Management, L.P. | 10% Owner | Open Market Sale | -12,182 | 2.37 | -28,871.34 | -12,0% | |
| 2026-01-15 | Saba Capital Management, L.P. | 10% Owner | Open Market Sale | -25,000 | 2.30 | -57,500.00 | -23,9% | |
| 2026-01-14 | Saba Capital Management, L.P. | 10% Owner | Open Market Sale | -77,688 | 2.25 | -174,798.00 | -72,6% | |
| 2026-01-13 | Saba Capital Management, L.P. | 10% Owner | Open Market Sale | -29,777 | 2.19 | -65,211.63 | -27,1% | |
| 2026-01-12 | FalconX Holdings Ltd | 10% Owner | Open Market Sale | -192,307 | 1.97 | -377,940.95 | -157,0% | |
| 2026-01-12 | FalconX Holdings Ltd | 10% Owner | Open Market Sale | -47,281 | 1.97 | -92,921.35 | -38,6% | |
| 2026-01-09 | FalconX Holdings Ltd | 10% Owner | Open Market Sale | -269,321 | 1.93 | -518,523.72 | -215,4% | |
| 2026-01-09 | FalconX Holdings Ltd | 10% Owner | Open Market Sale | -260,411 | 1.93 | -501,369.30 | -208,3% | |
| 2025-08-27 | Ruemler Timothy James | Director | Open Market Sale | -5,000 | 16.58 | -82,875.00 | -34,4% | |
| 2025-08-27 | Ruemler Timothy James | Director | Open Market Sale | -5,000 | 16.75 | -83,750.00 | -34,8% | |
| 2025-08-27 | Ruemler Timothy James | Director | Open Market Sale | -5,000 | 17.09 | -85,461.00 | -35,5% | |
| 2025-08-27 | Ruemler Timothy James | Director | Open Market Sale | -5,000 | 16.54 | -82,700.00 | -34,4% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 100 | 9.60 | 960.00 | +0,4% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 100 | 9.69 | 969.00 | +0,4% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 118 | 9.63 | 1,136.34 | +0,5% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 5,000 | 10.63 | 53,167.50 | +22,1% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 4,682 | 9.69 | 45,368.58 | +18,8% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 5,000 | 10.50 | 52,500.00 | +21,8% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 5,000 | 11.84 | 59,200.00 | +24,6% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 5,000 | 11.22 | 56,100.00 | +23,3% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 5,000 | 12.00 | 60,000.00 | +24,9% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 5,000 | 12.48 | 62,400.00 | +25,9% | |
| 2025-08-25 | Ruemler Timothy James | Director | Open Market Purchase | 5,000 | 12.50 | 62,500.00 | +26,0% | |
| 2025-08-22 | DANNER PAUL K | Director | Open Market Purchase | 400,000 | 6.41 | 2,564,000.00 | +1065,1% | |
| 2025-08-22 | Monroe Jason L. | Director | Open Market Purchase | 80,000 | 6.41 | 512,800.00 | +213,0% | |
| 2025-08-22 | Crescenzo Andrew R. | Director, Officer, Chief Financial Officer | Open Market Purchase | 40,000 | 6.41 | 256,400.00 | +106,5% | |
| 2025-08-22 | Christiansen Soren Bo | Director | Open Market Purchase | 80,000 | 6.41 | 512,800.00 | +213,0% | |
| 2025-08-22 | Hayes Robert Michael | Director | Open Market Purchase | 100,000 | 6.41 | 641,000.00 | +266,3% | |
| 2025-08-22 | Simpson Brenda Baird | Director | Open Market Purchase | 20,000 | 6.41 | 128,200.00 | +53,3% | |
| 2025-07-15 | DANNER PAUL K | Director | Open Market Purchase | 5 | 20.00 | 100.00 | 0,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.